Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma-Reference-Cited by-同舟云学术

Engineering a HemoMap Nanovaccine for Inducing Immune Responses against Melanoma

Published:2022-11-16 Issue:47 Volume:14 Page:52634-52642
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Dai Hengheng¹,Huang Ying²,Guo Jingyi¹,Li Lin³,Ke Yaohua⁴,Cen Lanqi¹,Meng Fanyan⁴,Chen Xinjie¹,Liu Baorui¹⁴^ORCID,Qian Xiaoping⁴

Affiliation:

1. The Comprehensive Cancer Centre, China Pharmaceutical University Nanjing Drum Tower Hospital, 321 Zhongshan Road, Nanjing 210008, China

2. The Comprehensive Cancer Centre, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing 210008, China

3. Department of Pathology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing 210008, China

4. The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing 210008, China

Funder

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c14379

Reference21 articles.

1. Current state of melanoma diagnosis and treatment

2. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

3. Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

4. Vaccine Therapies for Cancer: Then and Now

5. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in protein subunit vaccines against tuberculosis;Frontiers in Immunology;2023-08-15